Pharmacia and Upjohn gains Pap screening device:
This article was originally published in Clinica
Executive Summary
Pharmacia & Upjohn has struck a joint marketing agreement with Trylon, a privately-owned medtech developer in Torrance, California. The deal relates to Trylon's Pap Plus Speculoscopy (PPS) which is to be launched in March. Trylon's technology is based on the use of chemical light technology in diagnostics and other applications. PPS is the company's first product and combines a visual examination speculoscopy with the standard Pap smear into simple primary cervical screening tests.